HK1198746A1 - Medical device comprising boswellic acid - Google Patents

Medical device comprising boswellic acid

Info

Publication number
HK1198746A1
HK1198746A1 HK14112262.0A HK14112262A HK1198746A1 HK 1198746 A1 HK1198746 A1 HK 1198746A1 HK 14112262 A HK14112262 A HK 14112262A HK 1198746 A1 HK1198746 A1 HK 1198746A1
Authority
HK
Hong Kong
Prior art keywords
medical device
boswellic acid
boswellic
acid
medical
Prior art date
Application number
HK14112262.0A
Other languages
English (en)
Chinese (zh)
Inventor
麥可
．米爾伯克
路卡斯布魯查
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1198746A1 publication Critical patent/HK1198746A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/34—Carboxylic acids; Esters thereof with monohydroxyl compounds
    • C08G18/348—Hydroxycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/77—Polyisocyanates or polyisothiocyanates having heteroatoms in addition to the isocyanate or isothiocyanate nitrogen and oxygen or sulfur
    • C08G18/771—Polyisocyanates or polyisothiocyanates having heteroatoms in addition to the isocyanate or isothiocyanate nitrogen and oxygen or sulfur oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK14112262.0A 2011-06-21 2014-12-04 Medical device comprising boswellic acid HK1198746A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161499642P 2011-06-21 2011-06-21
US201161522169P 2011-08-10 2011-08-10
PCT/US2012/043462 WO2012177825A1 (en) 2011-06-21 2012-06-21 Medical device comprising boswellic acid

Publications (1)

Publication Number Publication Date
HK1198746A1 true HK1198746A1 (en) 2015-06-05

Family

ID=47422933

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112262.0A HK1198746A1 (en) 2011-06-21 2014-12-04 Medical device comprising boswellic acid

Country Status (8)

Country Link
US (2) US11123364B2 (xx)
EP (2) EP3597206A1 (xx)
JP (2) JP6302835B2 (xx)
KR (1) KR101723272B1 (xx)
CN (1) CN103889434B (xx)
HK (1) HK1198746A1 (xx)
TW (1) TWI465243B (xx)
WO (1) WO2012177825A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014004304A (es) * 2013-04-09 2015-05-07 Dow Quimica Mexicana S A De C V Composicion adhesiva de curado rapido.
EP3079751B1 (en) * 2013-12-12 2019-04-17 Hollister Incorporated Water disintegrable flushable catheter with a hydrophilic coating
US11759492B2 (en) 2014-10-21 2023-09-19 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag Extract from a plant of the genus Boswellia and related products and uses
EP3452127A1 (en) * 2016-05-03 2019-03-13 Bvw Holding AG Multiphase gel
WO2021090054A1 (en) * 2019-11-05 2021-05-14 Inventia Healthcare Limited Gut-protective compositions comprising boswellic acid
CN110746303A (zh) * 2019-11-15 2020-02-04 云南大学 一种咖啡豆的处理方法及其提取物提纯方法
KR102354663B1 (ko) * 2020-02-03 2022-01-24 윤경태 콘택트 렌즈 및 이의 제조방법
CN115039021A (zh) * 2020-02-03 2022-09-09 尹景泰 一种隐形眼镜及其制造方法

Family Cites Families (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042558A1 (de) * 1980-11-12 1982-06-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von kaelteflexiblen, gegebenenfalls zellhaltigen polyurethanelastomeren
US5064823A (en) * 1988-08-24 1991-11-12 Research Triangle Institute Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
US5268178A (en) 1989-09-25 1993-12-07 The Board Of Regents, The University Of Texas System Biodegradable antibiotic implants and methods of their use in treating and preventing infections
US5411737A (en) 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5519008A (en) 1992-09-10 1996-05-21 Glycomed Incorporated Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules ELAM-1 (E-selectin) and LECAM-1 (L-selectin)
US5527890A (en) 1993-04-16 1996-06-18 Glycomed Incorporated Derivatives of triterpenoid acids and uses thereof
DK44193D0 (da) 1993-04-20 1993-04-20 Euromed I S Saarforbinding og klaebemiddel til en saarforbinding eller lignende
US5947893A (en) 1994-04-27 1999-09-07 Board Of Regents, The University Of Texas System Method of making a porous prothesis with biodegradable coatings
DE4444288A1 (de) 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
DE4445728A1 (de) 1994-12-21 1996-06-27 Simmet Th Prof Dr Verwendung von Boswelliasäure zur Behandlung von Hirntumoren
US5629351A (en) 1995-04-13 1997-05-13 Council Of Scientific & Industrial Research Boswellic acid compositions and preparation thereof
US5676967A (en) 1995-04-18 1997-10-14 Brennen Medical, Inc. Mesh matrix wound dressing
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
DE19531067A1 (de) 1995-08-23 1997-02-27 Hermann P T Prof Dr Med Ammon Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität
GB9602111D0 (en) 1996-02-02 1996-04-03 Unilever Plc Personal care composition
TW505653B (en) 1996-02-26 2002-10-11 Meiji Seika Co Triterpene derivatives possessing an effect of treating liver diseases and pharmacentical compositions containing the same
US5691386A (en) 1996-04-16 1997-11-25 Shaman Pharmaceuticals, Inc. Triterpenoid compound for the treatment of diabetes
US6143037A (en) * 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
AU1942197A (en) 1996-07-02 1998-01-21 Pola Chemical Industries Inc. Photoaging inhibitor and skin-care preparation
US6080725A (en) * 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
US5888514A (en) 1997-05-23 1999-03-30 Weisman; Bernard Natural composition for treating bone or joint inflammation
US6022554A (en) 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
AU761879B2 (en) 1998-05-19 2003-06-12 Research Development Foundation Triterpene compositions and methods for use thereof
US6703047B2 (en) 2001-02-02 2004-03-09 Incept Llc Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
CA2306486C (en) * 1998-10-19 2008-12-09 Zila, Inc. Method and compositions for in situ formation of protective and/or medicated films on body tissue
GB9906914D0 (en) 1999-03-26 1999-05-19 Quest Int Compositions containing boswellia extracts
US6534086B1 (en) 2000-03-06 2003-03-18 Metagenics, Inc. Composition and method for treatment of inflammation and pain in mammals
AU4450600A (en) 1999-04-30 2000-11-17 Sabinsa Corporation Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
JP5140220B2 (ja) 1999-05-27 2013-02-06 バイオコンパテイブルズ・ユーケイ・リミテツド 局所的な薬剤送達
US6323183B1 (en) 1999-06-02 2001-11-27 Ornella Flore Composition for and method of treatment using triterpenoids
ES2218401T3 (es) 2000-03-28 2004-11-16 Birken Gmbh Emulsion que contiene un extracto de plantas que incluye triterpeno, procedimiento para la preparacion de la emulsion asi como para la obtencion del extracto de plantas.
US6492429B1 (en) 2000-07-10 2002-12-10 N.V. Nutricia Composition for the treatment of osteoarthritis
FR2811984B1 (fr) 2000-07-19 2004-02-06 Pharmascience Lab Procede de preparation d'un ester de corps gras et son utilisation dans les domaines pharmaceutique, cosmetique ou alimentaire
US6534693B2 (en) 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7749539B2 (en) 2000-11-30 2010-07-06 Efrat Biopolymers Ltd. Polymeric formulations for drug delivery
KR100446101B1 (ko) 2000-12-07 2004-08-30 주식회사 삼양사 수난용성 약물의 서방성 제형 조성물
US6777004B1 (en) 2001-03-30 2004-08-17 Council Of Scientific & Industrial Research Composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same
US7270835B2 (en) 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7524824B2 (en) 2003-09-04 2009-04-28 Pacific Arrow Limited Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
KR100416608B1 (ko) 2002-01-16 2004-02-05 삼성전자주식회사 반도체 메모리 장치 및 그의 제조방법
ATE513553T1 (de) 2002-03-05 2011-07-15 Laila Impex Verfahren zur herstellung einer fraktion, die bis zu 100 mit 3-o-acetyl-11-keto-beta- boswellinsäure aus einem extrakt, der ein gemisch aus boswellinsäuren enthält, angereichert ist
US20030199581A1 (en) 2002-03-13 2003-10-23 Seligson Allen L. Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid ("AKBA") industrial manufacture and uses
US7371889B2 (en) 2002-03-15 2008-05-13 Sami Labs Limited Chemical entities with multiple modes of anti-inflammatory action
US7112573B2 (en) 2002-04-19 2006-09-26 Iowa Research, The University Foundation Isoflavone and triterpene glycosides from soybeans
EP1507541A4 (en) 2002-05-13 2009-06-03 Dartmouth College HEMMER AND APPLICATION METHOD THEREFOR
US7438925B2 (en) 2002-08-26 2008-10-21 Biovention Holdings Ltd. Drug eluting coatings for medical implants
AU2003296417A1 (en) 2002-12-09 2004-06-30 Shaklee Corporation MODIFICATION OF CYCLOOXYGENASE AND LIPOXYGENASE ACTIVITY WITH ASTERIDAE EXTRACTS AND OPTIONALLy BOSWELLIC ACID
CN1271083C (zh) 2002-12-10 2006-08-23 杭州浙大力夫生物科技有限公司 从竹子中提取的三萜总皂甙元的组成、方法及其用途
US20090264377A1 (en) 2002-12-27 2009-10-22 Linda Saxe Einbond Anti-neoplastic compositions comprising extracts of black cohosh
US20090186837A1 (en) 2002-12-27 2009-07-23 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
EP1603583A2 (de) 2003-03-18 2005-12-14 KeyNeurotek AG Verwendung von weihrauch oder seinen hydrierungsprodukten zur prophylaxe und/oder behandlung von zerebraler ischemie und/oder schedel/hirntrauma
ITMI20031311A1 (it) 2003-06-27 2004-12-28 Indena Spa Formulazioni per il trattamento di disturbi artrosici.
US8802161B2 (en) 2003-08-02 2014-08-12 Florida Agricultural And Mechanical University Herbal composition and method of use for the treatment of cancer
CA2437639C (en) 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
US7858110B2 (en) 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
US7744861B2 (en) * 2003-09-17 2010-06-29 Nektar Therapeutics Multi-arm polymer prodrugs
AU2004279256B2 (en) 2003-10-10 2008-04-17 Sk Chemicals Co., Ltd. Triterpene compounds which are effective on improvement of brain function
KR101223761B1 (ko) 2003-10-24 2013-01-18 바스프 뷰티 케어 솔루션즈 프랑스 에스에이에스 식물 추출물 및 그의 약학용 및 화장용 용도
US7582314B2 (en) 2003-12-03 2009-09-01 Sami Labs Ltd. Compositions and methods for the management of hyperproliferative dermatological conditions
GB2409644B (en) 2003-12-31 2005-12-21 Igennus Ltd Formulation comprising eicosapentaenoic acid or an ester thereof and a triterpene or an ester thereof
EP1555278A1 (en) 2004-01-15 2005-07-20 Innocore Technologies B.V. Biodegradable multi-block co-polymers
DE602005025734D1 (de) 2004-02-25 2011-02-17 Meiji Seika Kaisha Triterpen-hydroxylase
US6979325B2 (en) 2004-02-27 2005-12-27 Reddy Usha P Post circumcision diaper
DE102004030044A1 (de) 2004-06-22 2006-01-12 Birken Gmbh Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
GB0413954D0 (en) 2004-06-22 2004-07-28 Altunkaya Ali Compositions for topical treatment
US20060009839A1 (en) 2004-07-12 2006-01-12 Scimed Life Systems, Inc. Composite vascular graft including bioactive agent coating and biodegradable sheath
US20070231345A1 (en) 2004-08-02 2007-10-04 Muhammed Majeed Medicament containing natural leucotriene inhibitors singly or in combination with bioavailable organic selenium supplement for hyperproliferative dermatological conditions and therapeutic methods thereof
EP1796693A2 (en) 2004-08-26 2007-06-20 Chandrashekhar P. Pathak Implantable tissue compositions and method
EP1827377B1 (en) 2004-12-14 2008-03-19 Novartis AG In-situ forming implant for animals
JP5134530B2 (ja) 2005-03-07 2013-01-30 ライラ ニュートラシューティカルズ ボスウェル酸及び選択的に濃縮したボスウェル酸の新規な塩、ならびにそのための方法
AU2006244393B2 (en) 2005-05-05 2012-06-21 Cook Biotech Incorporated Implantable materials and methods for inhibiting tissue adhesion formation
WO2007011674A2 (en) 2005-07-15 2007-01-25 Baker Donald J Compositions and methods for treating and preventing inflammatory and/or degenerative processes in humans and other animals
US8574627B2 (en) 2006-11-06 2013-11-05 Atrium Medical Corporation Coated surgical mesh
KR100704006B1 (ko) 2005-09-29 2007-04-04 성균관대학교산학협력단 항암 활성을 갖는 봄맞이 추출물 및 이로부터 분리된 트리테르펜 사포닌 화합물
EP1973426A2 (en) 2005-11-03 2008-10-01 Southwest Immunology Inc. Compositions for preventing and reducing delayed onset muscle soreness
WO2009113972A2 (en) 2006-02-08 2009-09-17 Tyrx Pharma, Inc. Temporarily stiffened mesh prostheses
US7741273B2 (en) 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
EP2012795A4 (en) 2006-04-13 2009-07-22 Univ Minnesota THERAPEUTIC TRITERPENOIDS
US20080020998A1 (en) 2006-07-24 2008-01-24 Muhammed Majeed Sustained release compositions for the therapeutic management of pain, inflammation and inflammation-associated disorders and prophylactic/ therapeutic methods thereof
US20080275117A1 (en) 2006-09-21 2008-11-06 Dan Li Compositions and Methods Comprising Boswellia Species
US20100190968A1 (en) 2006-10-24 2010-07-29 Bong Cheol Kim Oleanane triterpene saponin compounds which are effective on treatment of dementia and mild cognitive impairment (mci) and improvement of cognitive function
WO2008063441A2 (en) 2006-11-16 2008-05-29 The Procter & Gamble Company Personal care composition
CN101631568B (zh) 2007-03-12 2012-08-22 尼克塔治疗公司 低聚物-蛋白酶抑制剂偶联物
US8192768B2 (en) 2007-04-03 2012-06-05 Laila Impex Synergistic anti-inflammatory and antioxidant dietary supplement compositions
US20090169651A1 (en) 2007-06-28 2009-07-02 Muhammed Majeed Anti-skin damage compositions with complimentary dual mode of action
US8383594B2 (en) * 2007-08-07 2013-02-26 Sami Labs Limited Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals
EP2195361B1 (en) 2007-10-03 2014-11-26 Polynovo Biomaterials Limited High modulus polyurethane and polyurethane/urea compositions
CN101434635B (zh) 2007-11-16 2012-05-16 上海华拓医药科技发展股份有限公司 一类具抗肿瘤活性的水溶性酚性三萜化合物及其制备方法
US8269026B2 (en) 2008-01-03 2012-09-18 Vertex Pharmaceuticals Incorporated Lupane derivatives useful for treating HIV
CL2008000156A1 (es) * 2008-01-18 2008-08-01 Igloo Zone Chile S A Gel estable hidrofilo en base a un polimero para aplicacion topica porque comprende quitosano disuelto en un solvente; proceso para obtener el gel para uso topico antes mencionado; uso del gel.
US20090298938A1 (en) 2008-03-11 2009-12-03 Council Of Scientific & Industrial Research Use of semi synthetic analogues of boswellic acids for anticancer activity
DE102008017496A1 (de) 2008-04-04 2009-10-15 Medeon Pharmaceuticals Gmbh Verwendung von Boswelliasäure und Boswelliasäurederivaten zur Herstellung von Arzneimitteln zur Therapie von Multipler Sklerose
ES2326065B1 (es) 2008-03-28 2010-07-08 Consejo Superior De Investigaciones Cientificas (Csic) Utilizacion de un triterpeno pentaciclico para la preparacion de una composicion farmaceutica destinada al tratamiento de la esclerosis multiple.
US8557273B2 (en) 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
US9427297B2 (en) 2008-05-09 2016-08-30 Boston Scientific Scimed, Inc. Surgical meshes with radiopaque coatings
WO2010071864A1 (en) * 2008-12-19 2010-06-24 Ethicon, Incorporated Treatment of lung and pulmonary diseases and disorders
CA2748296C (en) 2008-12-23 2017-03-21 Surmodics Pharmaceuticals, Inc. Implantable composites and compositions comprising releasable bioactive agents
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
WO2011012715A1 (en) * 2009-07-31 2011-02-03 Ascendis Pharma As Biodegradable polyethylene glycol based water-insoluble hydrogels
US20110135703A1 (en) 2009-12-08 2011-06-09 Shipp John I Antimicrobial Coating for Surgical Implants and Method of Use
WO2013112381A2 (en) 2012-01-24 2013-08-01 Bvw Holding Ag New class of anti-adhesion hydrogels with healing aspects

Also Published As

Publication number Publication date
US11123364B2 (en) 2021-09-21
JP2017222660A (ja) 2017-12-21
CN103889434A (zh) 2014-06-25
TWI465243B (zh) 2014-12-21
CN103889434B (zh) 2017-02-15
EP2723357A4 (en) 2015-04-01
KR20140022108A (ko) 2014-02-21
EP2723357A1 (en) 2014-04-30
US20140301971A1 (en) 2014-10-09
JP6302835B2 (ja) 2018-03-28
WO2012177825A1 (en) 2012-12-27
KR101723272B1 (ko) 2017-04-18
US20220031734A1 (en) 2022-02-03
EP3597206A1 (en) 2020-01-22
JP2014517070A (ja) 2014-07-17
TW201306827A (zh) 2013-02-16

Similar Documents

Publication Publication Date Title
HK1204900A1 (en) Ingestible medical device
EP2786713A4 (en) MEDICAL DEVICE
IL234856A0 (en) A diverting device for severing tissue
EP2664268A4 (en) MEDICAL DEVICE
EP2716207A4 (en) ENDOSCOPE DEVICE
EP2716206A4 (en) ENDOSCOPIC DEVICE
LT2939601T (lt) Magnetinis medicininis įrenginys
EP2744426A4 (en) SURGICAL DEVICE
EP2735258A4 (en) MEDICAL DEVICE
GB201121874D0 (en) Integrated medical device
EP2581030A4 (en) ENDOSCOPE DEVICE
EP2671498A4 (en) ENDOSCOPE DEVICE
IL232943A0 (en) Catheter connection devices
HK1198746A1 (en) Medical device comprising boswellic acid
EP2724658A4 (en) ENDOSCOPIC DEVICE
EP2752146A4 (en) CAPTURED MEDICINE PRODUCT
EP2937110A4 (en) MEDICAL DEVICE
EP2601881A4 (en) MEDICAL DEVICE
EP2638846A4 (en) MEDICAL DEVICE
EP2851032A4 (en) ASSISTANCE DEVICE FOR MEDICAL OPERATION
EP2676594A4 (en) ENDOSCOPE DEVICE
EP2742851A4 (en) MEDICAL DEVICE
EP2787383A4 (en) ENDOSCOPE DEVICE
EP2870942A4 (en) SURGERY AUXILIARY DEVICE
PL2717826T3 (pl) Podnoszona leżanka dla pacjenta